Mortality is a basic indicator of health, and monitoring of mortality is fundamental for health planning, risk assessment and public health action. There is a demand for standardised robust and comparable estimates to identify changes in mortality patterns in a timely or near real-time manner to assess and react on changes.
related to Christmas and New Year holidays 1 . However, influenza is recognised as one of the main contributing factors of winter excess mortality.
A common method to assess winter excess mortality estimates, based on predefined periods with no or ignorable influenza activity, is by using the Serfling method 2, 3 . The baseline for the Serfling model, which is usually fitted with a cyclic variation over the year, can be compared with the observed number of deaths, and the difference (the residual) presented as an estimate of excess mortality.
Since 2009, the network for European monitoring of excess mortality for public health action (EuroMOMO) has monitored weekly excess all-cause mortality 4 , using this method. Using this method, excess mortality may be an over-or underestimation of influenzaassociated mortality, depending on the impact of non-influenza morbidity on mortality during the winter.
To obtain specific estimates of influenza-associated mortality, parameters representing influenza activity can be included in a time series model, instead of excluding periods with influenza activity from the estimation of baseline mortality 3, [5] [6] [7] . In this approach, excess mortality associated with influenza is determined directly from influenza activity data and not as a residual, which will also be affected by non-influenza factors.
Within the EuroMOMO network, we developed a model to estimate influenza-associated mortality based on influenza activity in the population while controlling for extreme ambient temperatures, the FluMOMO model. This model can be used at the national level or at the European level to support risk assessment and health planning in connection with seasonal influenza epidemics and in a pandemic situation, and has the potential for timely, in-season use.
The objective of this study was to describe the statistical model, FluMOMO, and apply it to estimate influenza-associated mortality in
Denmark for the seasons 2010/11 to 2016/17.
| MATERIAL S AND ME THODS
First, we describe the FluMOMO model and consider how the influenza activity and extreme ambient temperatures variables were defined. Secondly, we describe data sources, and finally analytical methods.
| The FluMOMO model
The model is a multivariable time series model with weekly number of deaths as dependent variable. We use a multiplicative Poisson regression with overdispersion and ISO-week as time unit. Influenza activity (IA) and extreme temperature (ET) are included as independent variables. The residual variation is post-regression corrected for skewness by applying a ⅔-power correction 8 A general formulation of the regression:
where l is the link function (ie logarithm in a multiplicative model),
X is the observed number of deaths and t is calendar week. Seasonyear (s) is defined as the period from week 27 to week 26 the following year, and p represents 4 parameters reflecting extreme temperature.
The baseline consists of a trend and seasonality expressed as 2 sine waves of 1 year and half year periods: sin(2π*t/(365.25/7)) + cos(2π*t/(365.25/7)), sin(2π*t/ ((365.25/2)/7)) + cos(2π*t/((365.25/2)/7)), respectively. The significance of the trend and the 2 sine waves is tested according to predefined levels, see below.
We estimate a separate effect of IA for each season and not for the entire period. The rationale for this relates to the fact that the type of circulating influenza virus and the match with the influenza vaccine will vary from one season to another.
Four parameters (ET t,1 to ET t,4 ) for ambient temperature were included, representing extreme cold in the winter (week 40 to week 20 the following year), where it may be associated with excess deaths, and extreme cold in the summer (week 21-39), where it may have a benign effect. Conversely, periods with extreme heat may be associated with excess mortality in the summer but a benign effect in the winter.
We include a lag-effect of the explanatory variables, that is, a carry-over effect of IA or ET from earlier weeks. Length of the lags is predefined as external parameters, and dIA and dET represent the delay in the formula.
The model estimates the baseline as well as the effect of IA and ET simultaneously, controlled for one another, that is, the baseline correlates to IA and ET.
| Expected number of deaths
The expected mean number of deaths including both IA and ET as explanatory variables will be
The expected baseline will be Expected mean number of deaths if only IA or ET had an effect will be Hence, the expected mean excess number of deaths associated with IA t and ET t will be ( Figure 1 ):
For post-estimation ⅔-power correction of residual variation and cumulated estimates see Appendix A.
| Influenza activity (IA)
A commonly used syndromic indicator of IA is the frequency of 
| Extreme ambient temperatures
Danish weather stations register daily average temperature as well as daily minimum and maximum temperature. Averages over each of these daily temperatures, weighted by the populations in the 5 Danish regions, were used as the overall Danish daily temperature, and minimum and maximum temperature for that day. Weekly temperature as well as weekly minimum and maximum temperature was calculated as the weekly mean of each of the overall daily temperatures, respectively. Using each of these mean weekly temperatures, we estimated the expected weekly temperature, and expected minimum and maximum temperatures, in general linear models with a yearly seasonal variation, fitted as a sine wave.
Weeks with extreme temperatures were defined as weeks with a mean temperature above the expected maximum temperature or below the expected minimum temperature ( Figure 2 ). Nominal values were defined as how far the observed temperature was below or above the expected minimum or maximum.
| Data sources

| Deaths
Individual notifications of all-cause dates of deaths and dates of birth were obtained from the Danish Civil Registry.
| Influenza activity
The Danish sentinel surveillance system for influenza is a voluntary system of GPs providing weekly reports (week 40-20) on the total number of consultations and age-specific numbers of ILI consultations to Statens Serum Institut. Any ILI consultations which took place outside of week 40-20 were set to 0.
Electronic data on all patients swabbed at the general practitioners (GP) or at hospitals and tested for influenza virus by PCR were retrieved from the Danish Microbiology Database (MiBa) 12 , where these samples have been registered since 2010.
| Ambient temperatures
Data on daily temperatures registered at Danish weather stations was downloaded from the National Oceanic and Atmospheric
Administration Online Climate Data Directory 13 .
F I G U R E 1 Baseline, effect of influenza activity and extreme temperature (ET)
| Population
The size of the Danish population by age at the start of every quarter of the year was downloaded from Statistics Denmark
14
. The weekly size of each age group specific population was achieved by linear interpolation.
| Analyses
Analyses were performed separately for the age groups 0-4, 5-14, 15-64 and 65+ years of age, as well as for all ages.
A fatal outcome after infection with influenza virus will normally occur after a time-delay, where co-morbidity and complications may contribute. On this basis, we applied a 2 weeks lag for both IA and ET.
We included a trend and a half-yearly cycle if they contributed on a 5% level (P < .05), while yearly seasonality was included on a 10% level.
There may be other changes in mortality over calendar time than seasonality. Therefore, a trend is included in the baseline. Long-term changes may be modelled using a non-linear trend, for example, a spline. However, non-linear trends tend to be less stable at the ends, and if we intend to use the model for monitoring, interest will be in the ends, especially the right end, which informs the most recent Table 1) . Number of deaths and mortality rates by age group for each of the different IA indicators are shown in Table 1 and illustrated in Figure 5 .
| D ISCUSS I ON
Infection with the influenza virus may often lead to exacerbation of underlying chronic conditions or to secondary bacterial infections 15 .
Therefore, influenza is often not recorded as the primary cause of death, and using cause-specific data as an outcome may lead to underestimation of influenza-associated mortality. Furthermore, in most countries, cause of death is available with large delays.
Therefore, timely estimation of influenza-associated mortality should be based on all-cause mortality, although this outcome may be associated with loss of some specificity. The present work started as an initiative within the EuroMOMO network, with the aim of obtaining a direct and timely estimation of mortality associated with influenza.
In the present study based on Danish data, the model generally captures the background seasonal mortality pattern well. However,
F I G U R E 4 All-cause mortality rates using the FluMOMO model with Goldstein index
TA B L E 1 Influenza-associated mortality rates based on different influenza activity indicators for some weeks, the estimated effect of IA was negative. For small, insignificant negative effects, this will be within the statistical variation. A decision to exclude these weeks will cause a slight overestimation of influenza-associated mortality. However, negative effects that are statistically significant or seen over a long period may indicate a problem with a poor fit of the model, for example if the baseline is too high. Presently, there is no proper solution to this problem, which warrants more attention. From a biological standpoint, a negative effect of influenza can be interpreted as a "protective effect," which is implausible. To overcome this, many modellers present negative values as a nought 3, 16 . Along these lines, we excluded weeks with negative values from influenza-associated mortality. This choice is convenient because it facilitates dissemination of a public health message of influenza-associated mortality, but it warrants a more critical review. The effect of excluding weeks with negative effects of IA is shown in appendix B, showing results without this restriction.
Other respiratory pathogens are not directly included in the model, even though they may affect winter mortality. If they should be included in the model, care has to be taken to avoid collinearity, in particular when lags are included, as a lagged effect of one pathogen may be confounded by a direct impact of another pathogen 5, 15 .
Additionally, if included in the model, potential interactions may complicate the model and blur the estimates. However, this should not prevent further investigation.
Another factor of importance in the seasonal variation in mortality is ambient temperature or more precisely deviation from expected temperature, for example, cold snaps in the winter or heat waves in the summer 17, 18 . We have controlled influenza-associated mortality for temperature, but the pattern of the effect of temperature on F I G U R E 5 Influenza activity associated winter (week 40 to week 20 the following year) mortality rates using the FluMOMO model mortality has to be investigated further to be able to report valid estimates of this effect.
We estimated Danish influenza-associated mortality using 3 indicators of influenza activity (Table 1 and Figure 5 ). All 3 indicators show a similar pattern. ILI possibly overestimates influenza mortality as ILI may be caused by other respiratory pathogens. Using positive% as indicator for IA will reduce the effect of other respiratory pathogens, but may not, as ILI, reflect the dynamic in the population.
A combination of the 2, the Goldstein index, will reflect both the dynamic of transmission and limit overestimation due to other pathogens 10, 11 . Mortality associated with influenza based on the Goldstein index seems to be the most appropriate for Danish data, primarily because it is conservative. Using the Goldstein index, we found a median influenza-associated mortality rate of 8.2 per 100 000 population which is substantially lower-and probably more realistic-than a previous applied methodology that obtained a median mortality of 
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APPENDIX A P OS T-E S TI M ATI O N ⅔-P OWE R CO R R EC TI O N O F R E-S I D UA L VA R I A N CE
Formulation of the ⅔-power variance corrected residual variance (RVar), that is, the uncertainty or confidence intervals of the estimated mean effects:
Using the delta-method, the residual ⅔-power variances of ∆IA t or ∆ET t becomes where E(B t ) is the estimated baseline number of deaths and E(IA t ) is the expected number of deaths had the effect of ET t been zero.
Var(E(B t )) and Var(E(IA t )) are the regression variances. However, in a regression with a link function l, these are "only" known at the lscale. Using the link function log, as we do, the regression variance become where Var log (E(X t )) is the regression variance on the log-scale. Hence and likewise for ET t :
Confidence intervals are then calculated as:
where X t may be IA or ET, respectively.
CU M U L ATE D N U M B E R O F E XCE SS D E ATH S
The mean cumulated excess number of deaths over s weeks will be
Assuming independence between weeks, that is, no residual autocorrelation, then the ⅔-power variance corrected residual variance of the cumulated excess deaths over s weeks will be Confidence intervals are then calculated as:
where EB is baseline and X t may be IA or ET, respectively. 
